Olympus, a global technology leader in designing and delivering innovative solutions for medical and surgical procedures, announced the FDA clearance of the new EVIS X1 endoscopy system, along with two compatible gastrointestinal endoscopes.
Lumicell, Inc., a privately held company focused on innovative fluorescence-guided imaging technologies for cancer surgery, announced that results of the Investigation of Novel Surgical Imaging for Tumor Excision (INSITE).
CardieX Limited announced its new arterial health monitor, the CONNEQT Pulse (Pulse), has received 510(k) clearance from the U.S. Food and Drug Administration (FDA). Pulse is the only vital signs monitor targeted at home, clinician, and clinical trial use that provides measurements of both brachial blood pressure (the pressure at your arm) and central blood pressure (the pressure at your aorta/heart) in addition to multiple other vascular health biomarkers.
EnChroma – creators of glasses for color blindness – and the University of North Carolina at Chapel Hill’s Department of Health Sciences announced that special EnChroma glasses for color blindness will be available for students, faculty and staff who are Color Vision Deficient (CVD).
Orthofix Medical Inc. (NASDAQ:OFIX), a leading global spine and orthopedics company, announced the full commercial launch of two access retractor systems to aid surgeons during minimally invasive spine (MIS) procedures.
CodeSteri, a leading provider of disinfection solutions, is proud to announce the launch of PlaClin-M, a revolutionary device designed to help ensure a clean and safe environment in offices, commercial establishments, and public spaces. CodeSteri started from the Korean government project to combat new infectious diseases by the incumbent professor and MD of Hanyang University Emergency Medicine, Seoul.
Ancora Heart, Inc., a company developing a completely transcatheter device-based therapy to address heart failure (HF), announced that patients treated with the investigational AccuCinch® Ventricular Restoration System demonstrated improvement in HF patient outcomes and beneficial changes in the structure of the heart. The 12-month data were presented as part of a late-breaking clinical science session at the Technology and Heart Failure Therapeutics conference (THT 2023) and simultaneously published in the Journal of Cardiac Failure.
TransMed7, LLC announced the first clinical use of VacuPac®, a new self-contained external vacuum-assist attachment with a SpeedBird Universal and a Concorde US from the SpeedBird and Concorde families of vacuum-assisted, Single Insertion – Multiple Collection (SIMC® ) breast biopsy devices.
Lumicell, Inc., a privately held company focused on innovative fluorescence-guided imaging technologies for cancer surgery, announced a New Drug Application (NDA) for its LUMISIGHT™ Optical Imaging Agent has been submitted to the U.S. Food and Drug Administration (FDA).
Syft Technologies today announced the release of its next generation Selected Ion Flow Tube Mass Spectrometry (SIFT-MS) technology, Syft Tracer™, at Pittcon 2023. This innovation of real-time, direct injection mass spectrometry (MS) offers platform advancements such as greater sensitivity, unparalleled performance stability, and high reproducibility and repeatability that make the system an industry-scalable solution. Analytical workflows that require fast time to data, high throughput, and continuous operation will benefit significantly from Syft Tracer capabilities.